Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
Abroad (travel likely)RecruitingPHASE2
Conditions
Urothelial Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Daniel Geynisman, MD)Temple University Hospital at Broad Street, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Daniel Geynisman, MD)
Study leads
Daniel Geynisman, MD
Principal Investigator
Fox Chase Cancer Center